The final pathology report will clarify the tumor stage, lymph node status, and whether Pope Leo XIV will need additional ...

New analyses suggest that continuing an immunomodulator with anti-TNF therapy is associated with greater treatment ...

Experts examine how time toxicity may benefit stakeholders more than patients, why clinical trial access remains limited, and ...

Google’s AMIE interviewed patients before primary care visits, but researchers caution that the findings do not support using ...

Men are less likely than women to receive an obesity diagnosis, be referred for treatment, or engage in treatment, but ...

Between charting, prior authorizations, and portal messages, many doctors spend more hours on paperwork than on patients.

The FDA has granted Breakthrough Device Designation to the Trans-Abdominal Gastric Surgical System (TAGSS; Endo-TAGSS) for use in patients with medically refractory gastroparesis. The TAGSS system is ...

Real-world data show fezolinetant is linked to improved vasomotor symptoms, depression, and anxiety as early as 4 weeks.

Clinicians have few ways to tell if lecanemab is working in any given patient. A new study of blood proteins offers a first look at what a blood test might track.

Known differences in colorectal cancer characteristics between men and women are also observed in fecal immunochemical tests.

The government says it can fund the uplift without trade-offs, but the BMA and Unison warn it risks driving staff from the ...

The new guideline addresses sleep and mood in addition to vasomotor symptoms and includes the most current data on newer ...